Braveheart Bio reportedly pricing IPO above marketing range

Go back to Braveheart Bio reportedly pricing IPO above marketing range
(NASDAQ: BRVE) Delayed: 25.02 --0 (-0%)
Previous Close $25.02    52 Week High
Open $25.02    52 Week Low
Day High $25.02    P/E N/A 
Day Low $25.02    EPS
Volume 384